Axonal-Biostatem becomes Heva

Axonal-Biostatem rebrands as Heva, a subsidiary of Docaposte and a brand of La Poste Santé & Autonomie. With over 30 years of experience, Heva specializes in processing health data for research in an ethical, secure, and sovereign framework. The company offers comprehensive services for clinical research projects and non-interventional studies, catering to pharmaceutical, medical device, biotechnology, and academic sponsors. Heva's agile approach and medical expertise enable it to adapt to diverse projects, including clinical trials, Phase I to IV studies, Early Access Programs, and post-registration or pharmaco-epidemiological studies. Heva also provides post-market clinical monitoring for medical devices. Based in France, the company aims to be a key player in the industry. For more information, visit Docaposte at https://www.docaposte.com/secteurs/sante and Heva at https://hevaweb.com/fr.